For citations:
Titova T.A., Artamonova E.V. New treatment strategy for early hormone receptor-positive HER2-negative breast cancer: updated results of adjuvant abemaciclib trial in operable and locally advanced breast cancer. Medical alphabet. 2024;(17):53-57. (In Russ.) https://doi.org/10.33667/2078-5631-202417-53-57
Views PDF (Rus): 3
Email this article 